Blog Post by PharmaForce
PharmaForceMay 1, 20265 min read
The Next 340B Pressure Point: Mixed-Use Pharmacy
The "assumed eligibility" era ended today; as of May 1, 2026, AstraZeneca, BMS, and ...
Start Reading
PharmaForceApr 7, 20262 min read
Deeper Expertise, Better Outcomes: Meet Our New Chief Pharmacy and Strategy Officer
The 340B landscape is shifting. Health systems are under more scrutiny, managing more ...
Start Reading
PharmaForceMar 27, 20263 min read
AI in 340B: Managing Today's Complexity with 2019 Effort
At the 340B Winter Conference 2026, PharmaForce Chief Product Officer Anthony Velasquez ...
Start Reading
PharmaForceMar 27, 20268 min read
The 340B Rebate Model: What Just Happened and What Comes Next
First, a Quick Primer: How the 340B Discount Has Always Worked
Start Reading